Mineralocorticoid receptors in the central nervous system

Journal of Steroid Biochemistry and Molecular Biology

Volumn 56, Issue 1-6, 1996, Pages 179-183

  Funder, John W ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR;

ANIMAL TISSUE; BINDING AFFINITY; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DRUG RECEPTOR BINDING; GUINEA PIG; HUMAN; HUMAN TISSUE; NONHUMAN; PREGNANCY; RAT; SPECIES DIFFERENCE; TISSUE SPECIFICITY;

EID: 0029939426     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00235-9     Document Type: Conference Paper

References (44)

1. Rousseau G., Baxter J. D., Funder J. W., Edelman I. S. and Tomkins G. M.: Glucocorticoid and mineralocorticoid receptors for aldosterone. J. Steroid Biochem. 3 (1972) 219-227.
2. Funder J. W., Feldman D. and Edelman I. S.: Specific aldosterone binding in rat kidney and parotid. J. Steroid Biochem. 3 (1972) 209-218.
3. Funder J. W., Feldman D. and Edelman I. S.: The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology 92 (1973) 994-1004.
4. Feldman D., Funder J. W. and Edelman I. S.: Evidence for a new class of corticosterone receptors in the rat kidney. Endocrinology 92 (1973) 1429-1441.
5. de Kloet E. R., Wallach G. and McEwen B. S.: Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 96 (1975) 598-609.
6. Krozowski Z. S. and Funder J. W.: Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc. Natn. Acad. Sci. U.S.A. 80 (1983) 6056-6060.
7. Arriza J. L., Weinberger C., Glaser T., Handelin B. L., Houseman D. E. and Evans R. M.: Cloning of human mineralocorticoid receptor complementary DNA; structural and functional kinship with the glucocorticoid receptors. Science 237 (1987) 268-275.
8. Patel P. D., Sherman T. G., Goldman D. J. and Watson S. J.: Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA for rat hippocampus. Molec. Endocr. 3 (1989) 1877-1885.
9. Sheppard K. and Funder J. W.: Mineralocorticoid specificity of renal Type I receptors: in vivo binding studies. Am. J. Physiol. 252 (1987) E224-E229.
10. Funder J. W., Pearce P. T., Smith R. and Smith A. I.: Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science 242 (1988) 583-585.
11. Edwards C. R. W., Stewart P. M., Burt D., McIntyre M. A., de Kloet E. R., Brett L., Sutano W. S. and Monder C.: Localization of 11β-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 2 (1988) 986-989.
12. Albiston A., Obeyesekere V., Smith R. and Krozowski Z.: Cloning and tissue distribution of the human 11-beta hydroxysteroid dehydrogenase type II enzyme. Molec. Cell. Endocr. 105 (1994) R11-R17.
13. --dependent isoform of 11 β-hydroxysteroid dehydrogenase: cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 269 (1994) 25,959-25,962.
14. Naray-Fejes-Toth A. and Fejes-Toth G.: Expression cloning of the aldosterone target cell-specific 11β-hydroxysteroid dehydrogenase from rabbit collecting duct cells. Endocrinology 136 (1995) 2579-2586.
15. Cole T.: Cloning of the mouse 11β-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136 (1995) 4693-4696.
16. Whorwood C. B., Mason J. I., Ricketts M. L., Howie A. J. and Stewart P. M.: Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Molec. Cell. Endocr. 110 (1995) R7-R12.
17. Krozowski Z., Maguire J. A., Stein Oakley A. N., Dowling J., Smith R. E. and Andrews R. K.: Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocr. Metab. 80(7) (1995) 2203-2209.
18. Yang K. and Matthews S. G.: Cellular localization of 11β-hydroxysteroid dehydrogenase 2 gene expression in the ovine adrenal gland. Molec. Cell. Endocr. 111(2) (1995) R19-R23.
19. Mercer W. R. and Krozowski Z. S.: Localization of an 11β-hydroxysteroid dehydrogenase activity to the distal nephron of the rat kidney. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 130 (1992) 540-542.
20. Roland B. R., Krozowski Z. S. and Funder J. W.: GR, MR, 11β-HSD1 and 11β-HSD2 expression in rat brain and kidney: in situ studies. Molec. Cell. Endocr. 111 (1995) R1-R7.
21. Funder J. W., Pearce P., Myles K. and Roy L. P.: Apparent mineralocorticoid excess, pseudohypoaldosteronism and urinary electrolyte excretion: towards a redefinition of "mineralocorticoid" action. FASEB J. 4 (1990) 3234-3238.
22. Naray-Fejes-Toth A. and Fejes-Toth G.: Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am. J. Physiol. 259 (1990) F672-F678.
23. Arriza J., Simerly R. B., Swanson L. W. and Evans R. M.: Neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1 (1988) 887-900.
24. Pearce D. and Yamamoto K. R.: Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259 (1993) 1661-1665.
25. Roland B., Li K. and Funder J. W.: Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase Type 2 in rat brain. Endocrinology 136 (1995) 4697-4699.
26. de Kloet E. R., Versteeg D. H. G. and Kovacs G. L.: Aldosterone blocks the response to corticosterone in the raphehippocampal serotonin system. Brain Res. 264 (1983) 323-327.
27. Gomez-Sanchez E. P., Fort C. M. and Gomez-Sanchez C. E.: Interacerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am. J. Physiol. 258 (1990) E482-E484.
28. Gomez-Sanchez E. P., Venkataraman M. T. and Thwaites D.: ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 258 (1990) E649-E653.
29. Nestler E. J., Rainbow T. C., McEwen B. S. and Greengard P.: Corticosterone increases the level of protein 1, a neuron-specific protein in rat hippocampus. Science 212 (1981) 1162-1164.
30. Kwak S. P., Patel P. D., Thompson R. C., Akil H. and Watson S. J.: 5′-Heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinology 133 (1993) 2344-2350.
31. Reul J. M. H. M., Pearce P. T., Funder J. W. and Krozowski Z. S.: Type I and Type II corticosteroid receptor gene expression in the rat: effect of adrenalectomy and dexamethasone administration. Molec. Endocr. 3 (1989) 1674-1680.
32. Doyle D., Krozowski Z., Morgan F. J. and Funder J. W.: Analysis of renal and hippocampal type I and type II receptors by fast protein liquid chromatography. J. Steroid Biochem. 29 (1988) 415-421.
33. Claman N. H.: Corticosteroids and lymphoid cells. New Engl. J. Med. 287 (1972) 388-397.
34. Westphal U.: Steroid-protein interactions XIII. Concentration and binding affinities of corticosteroid binding globulins in sera of man, monkey, rat, rabbit and guinea-pig. Arch. Biochem. Biophys. 118 (1967) 556.
35. Kraft N., Hodgson A. J. and Funder J. W.: Glucocorticoid receptor and effector mechanisms: a comparison of the corticosensitive mouse with the corticoresistant guinea-pig. Endocrinology 104 (1979) 344-349.
36. Smith A. I., Wallace C. A., Moritz R. L., Simpson R. J., Schmauk-White L. B., Woodcock E. A. and Funder J. W.: Isolation, amino acid sequence and superagonist steroidogenic activity of guinea-pig ACTH. J. Endocr. 115(2) (1987) R2-R8.
37. Whipp G. T., Wintour E. M., Coghlan J. P. and Scoggins B. A.: Regulation of aldosterone in the guinea-pig: effect of oestrous cycle, pregnancy and sodium status. Aust. J. Exp. Biol. Med. 54 (1976) 71-78.
38. Myles K. and Funder J. W.: Type I (mineralocorticoid) receptors in the guinea-pig. Am. J. Physiol. 267 (1994) E268-E272.
39. Funder J. W.: Mineralocorticoids, glucocorticoids, receptors and response elements. Science 259 (1993) 1132-1133.
40. Trapp T., Rupprecht R., Castren M., Reul J. M. H. M. and Holsboer F.: Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 13 (1994) 1-20.
41. Rupprecht R., Reul J. M. H. M., van Steensel B., Spengler D., Soder M., Berning B., Holsboer F. and Damm K.: Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 247 (1993) 145-154.
42. Myles K. and Funder J. W.: Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am. J. Physiol, in press.
43. McEwen B. S., Lambdin L. T., Rainbow T. C. and De Nicola A. F.: Aldosterone effects of salt appetite in adrenalectomized rats. Neuroendocrinology 43 (1986) 38-43.
44. Lifton R. P., Dluhy R. G., Powers M., Rich G. M., Cook S., Ulick S. and Lalouel J.-M.: A chimaeric 11β-hydrolase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355 (1992) 262-265.